Valiant Laboratories Ltd Half Yearly Results

Gross Sales

93.02

40.36

71.1

110.95

162.04

Excise Duty

0

0

0

0

0

Net Sales

93.02

40.36

71.1

110.95

162.04

Other Operating Income

0

0

0

0

0

Other Income

-0.74

6.17

4.28

5.4

3.52

Total Income

92.28

46.53

75.38

116.36

165.56

Total Expenditure

88.57

49.49

81.94

108.53

142.18

PBIDT

3.71

-2.96

-6.56

7.83

23.38

Interest

0.12

0.06

0.04

0.04

0.07

PBDT

3.6

-3.02

-6.6

7.79

23.31

Depreciation

1.04

1.05

1.01

0.95

0.84

Minority Interest Before NP

0

0

0

0

0

Tax

-0.21

0.26

-2.91

1.93

4.73

Deferred Tax

-0.28

0.92

0.04

-0.15

0.09

Reported Profit After Tax

3.05

-5.25

-4.74

5.06

17.65

Minority Interest After NP

0

0

0

0

0

Net Profit after Minority Interest

3.05

-5.25

-4.74

5.06

17.65

Extra-ordinary Items

0

0

0

0

0

Adjusted Profit After Extra-ordinary item

3.05

-5.25

-4.74

5.06

17.65

EPS (Unit Curr.)

0.7

-0.33

0

1.55

5.42

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

43.45

43.45

43.45

32.56

32.56

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

3.98

-7.33

-9.22

7.05

14.42

PBDTM(%)

-

-

-

-

-

PATM(%)

3.27

-13

-6.66

4.56

10.89